A randomized embedded multifactorial adaptive platform for extra corporeal membrane oxygenation (REMAP ECMO) – design and rationale of the left ventricular unloading trial domain

The use of Extracorporeal Membrane Oxygenation (ECMO) remains associated with high rates of complications, weaning failure and mortality which can be partly explained by a knowledge gap on how to properly manage patients on ECMO support. To address relevant patient management issues, we designed a “...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American heart journal 2025-01, Vol.279, p.81-93
Hauptverfasser: van Steenwijk, Myrthe P.J., van Rosmalen, Joost, Elzo Kraemer, Carlos V., Donker, Dirk W., Hermens, Jeannine A.J.M., Kraaijeveld, Adriaan O., Maas, Jacinta J., Akin, Sakir, Montenij, Leon J., Vlaar, Alexander P.J., van den Bergh, Walter M., Oude Lansink-Hartgring, Annemieke, de Metz, Jesse, Voesten, Niek, Boersma, Eric, Scholten, Erik, Beishuizen, Albertus, Lexis, Chris P.H., Peperstraete, Harlinde, Schiettekatte, Simon, Lorusso, Roberto, Gommers, Diederik A.M.P.J., Tibboel, Dick, de Boer, Rudolf A., Van Mieghem, Nicolas M.D.A., Meuwese, Christiaan L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 93
container_issue
container_start_page 81
container_title The American heart journal
container_volume 279
creator van Steenwijk, Myrthe P.J.
van Rosmalen, Joost
Elzo Kraemer, Carlos V.
Donker, Dirk W.
Hermens, Jeannine A.J.M.
Kraaijeveld, Adriaan O.
Maas, Jacinta J.
Akin, Sakir
Montenij, Leon J.
Vlaar, Alexander P.J.
van den Bergh, Walter M.
Oude Lansink-Hartgring, Annemieke
de Metz, Jesse
Voesten, Niek
Boersma, Eric
Scholten, Erik
Beishuizen, Albertus
Lexis, Chris P.H.
Peperstraete, Harlinde
Schiettekatte, Simon
Lorusso, Roberto
Gommers, Diederik A.M.P.J.
Tibboel, Dick
de Boer, Rudolf A.
Van Mieghem, Nicolas M.D.A.
Meuwese, Christiaan L.
description The use of Extracorporeal Membrane Oxygenation (ECMO) remains associated with high rates of complications, weaning failure and mortality which can be partly explained by a knowledge gap on how to properly manage patients on ECMO support. To address relevant patient management issues, we designed a “Randomized Embedded Multifactorial Adaptive Platform (REMAP)” in the setting of ECMO (REMAP ECMO) and a first embedded randomized controlled trial (RCT) investigating the effects of routine early left ventricular (LV) unloading through intra-aortic balloon pumping (IABP). REMAP ECMO describes a registry-based platform allowing for the embedding of multiple response adaptive RCTs (trial domains) which can perpetually address the effect of relevant patient management issues on ECMO weaning success. A first trial domain studies the effects of LV unloading by means of an IABP as an adjunct to veno-arterial (V-A) ECMO versus V-A ECMO alone on ECMO weaning success at 30 days in adult cardiogenic shock patients admitted to the Intensive Care Unit (ICU). The primary outcome of this trial is “successful weaning from ECMO” being defined as a composite of survival without the need for mechanical circulatory support, heart transplantation, or left ventricular assist device (LVAD) at 30 days after initiation of ECMO. Secondary outcomes include the need for interventional escalation of LV unloading strategy, mechanistic endpoints, survival characteristics until 1 year after ECMO initiation, and quality of life. Trial data will be analysed using a Bayesian statistical framework. The adaptive design allows for a high degree of flexibility, such as response adaptive randomization and early stopping of the trial for efficacy or futility. The REMAP ECMO LV unloading study is approved by the Medical Ethical Committee of the Erasmus Medical Center and is publicly registered. This REMAP ECMO trial platform enables the efficient roll-out of multiple RCTs on relevant patient management issues. A first embedded trial domain will compare routine LV unloading by means of an IABP as an adjunct to V-A ECMO versus V-A ECMO alone. ClinicalTrials.gov, NCT05913622
doi_str_mv 10.1016/j.ahj.2024.10.010
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3120594186</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002870324002722</els_id><sourcerecordid>3134814054</sourcerecordid><originalsourceid>FETCH-LOGICAL-c306t-3b19425f6894e417078e36d49c7c6d00902399e2f56a5e97b0fc728ba195f883</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhS0EotPCA7BBltiURQY7cZxYrEaj4UdqVYS6jxz7ZurIiYPtjNqueAdepU_Ek-AwhQULNrav9Z1zr30QekXJmhLK3_VredOvc5KzVK8JJU_QihJRZbxi7ClaEULyrK5IcYJOQ-hTyfOaP0cnhWCsqihfoYcN9nLUbjD3oDEMLWidDsNso-mkis4babHUcormAHiyMnbODzgtGG6jl1g5PzkPiRqSPJkBdrd3exhlNG7E5193l5sveLe9vHqLf37_gTUEsx9xapo6L4i0SdHheAPYQhfxAcbojZqt9HgerZPajHscfw-SBpVmfIGeddIGePm4n6HrD7vr7afs4urj5-3mIlMF4TErWipYXna8FgwYrUhVQ8E1E6pSXBMiSF4IAXlXclmCqFrSqSqvW0lF2dV1cYbOj7aTd99mCLEZTFBgbXqjm0NT0JyUgtGaJ_TNP2jvZp-etlAFqykjJUsUPVLKuxA8dM3kzSD9XUNJsyTa9E1KtFkSXa5Soknz-tF5bgfQfxV_IkzA-yMA6ScOBnwTlIFRgTYeVGy0M_-x_wUC47Nc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3134814054</pqid></control><display><type>article</type><title>A randomized embedded multifactorial adaptive platform for extra corporeal membrane oxygenation (REMAP ECMO) – design and rationale of the left ventricular unloading trial domain</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>van Steenwijk, Myrthe P.J. ; van Rosmalen, Joost ; Elzo Kraemer, Carlos V. ; Donker, Dirk W. ; Hermens, Jeannine A.J.M. ; Kraaijeveld, Adriaan O. ; Maas, Jacinta J. ; Akin, Sakir ; Montenij, Leon J. ; Vlaar, Alexander P.J. ; van den Bergh, Walter M. ; Oude Lansink-Hartgring, Annemieke ; de Metz, Jesse ; Voesten, Niek ; Boersma, Eric ; Scholten, Erik ; Beishuizen, Albertus ; Lexis, Chris P.H. ; Peperstraete, Harlinde ; Schiettekatte, Simon ; Lorusso, Roberto ; Gommers, Diederik A.M.P.J. ; Tibboel, Dick ; de Boer, Rudolf A. ; Van Mieghem, Nicolas M.D.A. ; Meuwese, Christiaan L.</creator><creatorcontrib>van Steenwijk, Myrthe P.J. ; van Rosmalen, Joost ; Elzo Kraemer, Carlos V. ; Donker, Dirk W. ; Hermens, Jeannine A.J.M. ; Kraaijeveld, Adriaan O. ; Maas, Jacinta J. ; Akin, Sakir ; Montenij, Leon J. ; Vlaar, Alexander P.J. ; van den Bergh, Walter M. ; Oude Lansink-Hartgring, Annemieke ; de Metz, Jesse ; Voesten, Niek ; Boersma, Eric ; Scholten, Erik ; Beishuizen, Albertus ; Lexis, Chris P.H. ; Peperstraete, Harlinde ; Schiettekatte, Simon ; Lorusso, Roberto ; Gommers, Diederik A.M.P.J. ; Tibboel, Dick ; de Boer, Rudolf A. ; Van Mieghem, Nicolas M.D.A. ; Meuwese, Christiaan L. ; REMAP ECMO LV unloading study group ; REMAP ECMO LV unloading study group</creatorcontrib><description>The use of Extracorporeal Membrane Oxygenation (ECMO) remains associated with high rates of complications, weaning failure and mortality which can be partly explained by a knowledge gap on how to properly manage patients on ECMO support. To address relevant patient management issues, we designed a “Randomized Embedded Multifactorial Adaptive Platform (REMAP)” in the setting of ECMO (REMAP ECMO) and a first embedded randomized controlled trial (RCT) investigating the effects of routine early left ventricular (LV) unloading through intra-aortic balloon pumping (IABP). REMAP ECMO describes a registry-based platform allowing for the embedding of multiple response adaptive RCTs (trial domains) which can perpetually address the effect of relevant patient management issues on ECMO weaning success. A first trial domain studies the effects of LV unloading by means of an IABP as an adjunct to veno-arterial (V-A) ECMO versus V-A ECMO alone on ECMO weaning success at 30 days in adult cardiogenic shock patients admitted to the Intensive Care Unit (ICU). The primary outcome of this trial is “successful weaning from ECMO” being defined as a composite of survival without the need for mechanical circulatory support, heart transplantation, or left ventricular assist device (LVAD) at 30 days after initiation of ECMO. Secondary outcomes include the need for interventional escalation of LV unloading strategy, mechanistic endpoints, survival characteristics until 1 year after ECMO initiation, and quality of life. Trial data will be analysed using a Bayesian statistical framework. The adaptive design allows for a high degree of flexibility, such as response adaptive randomization and early stopping of the trial for efficacy or futility. The REMAP ECMO LV unloading study is approved by the Medical Ethical Committee of the Erasmus Medical Center and is publicly registered. This REMAP ECMO trial platform enables the efficient roll-out of multiple RCTs on relevant patient management issues. A first embedded trial domain will compare routine LV unloading by means of an IABP as an adjunct to V-A ECMO versus V-A ECMO alone. ClinicalTrials.gov, NCT05913622</description><identifier>ISSN: 0002-8703</identifier><identifier>ISSN: 1097-6744</identifier><identifier>EISSN: 1097-6744</identifier><identifier>DOI: 10.1016/j.ahj.2024.10.010</identifier><identifier>PMID: 39447716</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Aorta ; Balloon treatment ; Bayesian analysis ; Coronary vessels ; Edema ; Embedding ; Extracorporeal membrane oxygenation ; Extracorporeal Membrane Oxygenation - methods ; Health care facilities ; Heart transplantation ; Heart-Assist Devices ; Humans ; Intra-Aortic Balloon Pumping - methods ; Knowledge management ; Male ; Mechanical unloading ; Membranes ; Mortality ; Observational studies ; Oxygenation ; Patients ; Pulmonary arteries ; Quality of life ; Randomization ; Randomized Controlled Trials as Topic ; Registries ; Shock, Cardiogenic - therapy ; Survival ; Survival analysis ; Veins &amp; arteries ; Ventricle ; Ventricular assist devices ; Weaning</subject><ispartof>The American heart journal, 2025-01, Vol.279, p.81-93</ispartof><rights>2024 The Author(s)</rights><rights>Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.</rights><rights>2024. The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c306t-3b19425f6894e417078e36d49c7c6d00902399e2f56a5e97b0fc728ba195f883</cites><orcidid>0009-0000-3880-2605 ; 0000-0002-1901-1653</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0002870324002722$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39447716$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>van Steenwijk, Myrthe P.J.</creatorcontrib><creatorcontrib>van Rosmalen, Joost</creatorcontrib><creatorcontrib>Elzo Kraemer, Carlos V.</creatorcontrib><creatorcontrib>Donker, Dirk W.</creatorcontrib><creatorcontrib>Hermens, Jeannine A.J.M.</creatorcontrib><creatorcontrib>Kraaijeveld, Adriaan O.</creatorcontrib><creatorcontrib>Maas, Jacinta J.</creatorcontrib><creatorcontrib>Akin, Sakir</creatorcontrib><creatorcontrib>Montenij, Leon J.</creatorcontrib><creatorcontrib>Vlaar, Alexander P.J.</creatorcontrib><creatorcontrib>van den Bergh, Walter M.</creatorcontrib><creatorcontrib>Oude Lansink-Hartgring, Annemieke</creatorcontrib><creatorcontrib>de Metz, Jesse</creatorcontrib><creatorcontrib>Voesten, Niek</creatorcontrib><creatorcontrib>Boersma, Eric</creatorcontrib><creatorcontrib>Scholten, Erik</creatorcontrib><creatorcontrib>Beishuizen, Albertus</creatorcontrib><creatorcontrib>Lexis, Chris P.H.</creatorcontrib><creatorcontrib>Peperstraete, Harlinde</creatorcontrib><creatorcontrib>Schiettekatte, Simon</creatorcontrib><creatorcontrib>Lorusso, Roberto</creatorcontrib><creatorcontrib>Gommers, Diederik A.M.P.J.</creatorcontrib><creatorcontrib>Tibboel, Dick</creatorcontrib><creatorcontrib>de Boer, Rudolf A.</creatorcontrib><creatorcontrib>Van Mieghem, Nicolas M.D.A.</creatorcontrib><creatorcontrib>Meuwese, Christiaan L.</creatorcontrib><creatorcontrib>REMAP ECMO LV unloading study group</creatorcontrib><creatorcontrib>REMAP ECMO LV unloading study group</creatorcontrib><title>A randomized embedded multifactorial adaptive platform for extra corporeal membrane oxygenation (REMAP ECMO) – design and rationale of the left ventricular unloading trial domain</title><title>The American heart journal</title><addtitle>Am Heart J</addtitle><description>The use of Extracorporeal Membrane Oxygenation (ECMO) remains associated with high rates of complications, weaning failure and mortality which can be partly explained by a knowledge gap on how to properly manage patients on ECMO support. To address relevant patient management issues, we designed a “Randomized Embedded Multifactorial Adaptive Platform (REMAP)” in the setting of ECMO (REMAP ECMO) and a first embedded randomized controlled trial (RCT) investigating the effects of routine early left ventricular (LV) unloading through intra-aortic balloon pumping (IABP). REMAP ECMO describes a registry-based platform allowing for the embedding of multiple response adaptive RCTs (trial domains) which can perpetually address the effect of relevant patient management issues on ECMO weaning success. A first trial domain studies the effects of LV unloading by means of an IABP as an adjunct to veno-arterial (V-A) ECMO versus V-A ECMO alone on ECMO weaning success at 30 days in adult cardiogenic shock patients admitted to the Intensive Care Unit (ICU). The primary outcome of this trial is “successful weaning from ECMO” being defined as a composite of survival without the need for mechanical circulatory support, heart transplantation, or left ventricular assist device (LVAD) at 30 days after initiation of ECMO. Secondary outcomes include the need for interventional escalation of LV unloading strategy, mechanistic endpoints, survival characteristics until 1 year after ECMO initiation, and quality of life. Trial data will be analysed using a Bayesian statistical framework. The adaptive design allows for a high degree of flexibility, such as response adaptive randomization and early stopping of the trial for efficacy or futility. The REMAP ECMO LV unloading study is approved by the Medical Ethical Committee of the Erasmus Medical Center and is publicly registered. This REMAP ECMO trial platform enables the efficient roll-out of multiple RCTs on relevant patient management issues. A first embedded trial domain will compare routine LV unloading by means of an IABP as an adjunct to V-A ECMO versus V-A ECMO alone. ClinicalTrials.gov, NCT05913622</description><subject>Adult</subject><subject>Aorta</subject><subject>Balloon treatment</subject><subject>Bayesian analysis</subject><subject>Coronary vessels</subject><subject>Edema</subject><subject>Embedding</subject><subject>Extracorporeal membrane oxygenation</subject><subject>Extracorporeal Membrane Oxygenation - methods</subject><subject>Health care facilities</subject><subject>Heart transplantation</subject><subject>Heart-Assist Devices</subject><subject>Humans</subject><subject>Intra-Aortic Balloon Pumping - methods</subject><subject>Knowledge management</subject><subject>Male</subject><subject>Mechanical unloading</subject><subject>Membranes</subject><subject>Mortality</subject><subject>Observational studies</subject><subject>Oxygenation</subject><subject>Patients</subject><subject>Pulmonary arteries</subject><subject>Quality of life</subject><subject>Randomization</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Registries</subject><subject>Shock, Cardiogenic - therapy</subject><subject>Survival</subject><subject>Survival analysis</subject><subject>Veins &amp; arteries</subject><subject>Ventricle</subject><subject>Ventricular assist devices</subject><subject>Weaning</subject><issn>0002-8703</issn><issn>1097-6744</issn><issn>1097-6744</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1u1DAUhS0EotPCA7BBltiURQY7cZxYrEaj4UdqVYS6jxz7ZurIiYPtjNqueAdepU_Ek-AwhQULNrav9Z1zr30QekXJmhLK3_VredOvc5KzVK8JJU_QihJRZbxi7ClaEULyrK5IcYJOQ-hTyfOaP0cnhWCsqihfoYcN9nLUbjD3oDEMLWidDsNso-mkis4babHUcormAHiyMnbODzgtGG6jl1g5PzkPiRqSPJkBdrd3exhlNG7E5193l5sveLe9vHqLf37_gTUEsx9xapo6L4i0SdHheAPYQhfxAcbojZqt9HgerZPajHscfw-SBpVmfIGeddIGePm4n6HrD7vr7afs4urj5-3mIlMF4TErWipYXna8FgwYrUhVQ8E1E6pSXBMiSF4IAXlXclmCqFrSqSqvW0lF2dV1cYbOj7aTd99mCLEZTFBgbXqjm0NT0JyUgtGaJ_TNP2jvZp-etlAFqykjJUsUPVLKuxA8dM3kzSD9XUNJsyTa9E1KtFkSXa5Soknz-tF5bgfQfxV_IkzA-yMA6ScOBnwTlIFRgTYeVGy0M_-x_wUC47Nc</recordid><startdate>202501</startdate><enddate>202501</enddate><creator>van Steenwijk, Myrthe P.J.</creator><creator>van Rosmalen, Joost</creator><creator>Elzo Kraemer, Carlos V.</creator><creator>Donker, Dirk W.</creator><creator>Hermens, Jeannine A.J.M.</creator><creator>Kraaijeveld, Adriaan O.</creator><creator>Maas, Jacinta J.</creator><creator>Akin, Sakir</creator><creator>Montenij, Leon J.</creator><creator>Vlaar, Alexander P.J.</creator><creator>van den Bergh, Walter M.</creator><creator>Oude Lansink-Hartgring, Annemieke</creator><creator>de Metz, Jesse</creator><creator>Voesten, Niek</creator><creator>Boersma, Eric</creator><creator>Scholten, Erik</creator><creator>Beishuizen, Albertus</creator><creator>Lexis, Chris P.H.</creator><creator>Peperstraete, Harlinde</creator><creator>Schiettekatte, Simon</creator><creator>Lorusso, Roberto</creator><creator>Gommers, Diederik A.M.P.J.</creator><creator>Tibboel, Dick</creator><creator>de Boer, Rudolf A.</creator><creator>Van Mieghem, Nicolas M.D.A.</creator><creator>Meuwese, Christiaan L.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7TS</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0009-0000-3880-2605</orcidid><orcidid>https://orcid.org/0000-0002-1901-1653</orcidid></search><sort><creationdate>202501</creationdate><title>A randomized embedded multifactorial adaptive platform for extra corporeal membrane oxygenation (REMAP ECMO) – design and rationale of the left ventricular unloading trial domain</title><author>van Steenwijk, Myrthe P.J. ; van Rosmalen, Joost ; Elzo Kraemer, Carlos V. ; Donker, Dirk W. ; Hermens, Jeannine A.J.M. ; Kraaijeveld, Adriaan O. ; Maas, Jacinta J. ; Akin, Sakir ; Montenij, Leon J. ; Vlaar, Alexander P.J. ; van den Bergh, Walter M. ; Oude Lansink-Hartgring, Annemieke ; de Metz, Jesse ; Voesten, Niek ; Boersma, Eric ; Scholten, Erik ; Beishuizen, Albertus ; Lexis, Chris P.H. ; Peperstraete, Harlinde ; Schiettekatte, Simon ; Lorusso, Roberto ; Gommers, Diederik A.M.P.J. ; Tibboel, Dick ; de Boer, Rudolf A. ; Van Mieghem, Nicolas M.D.A. ; Meuwese, Christiaan L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c306t-3b19425f6894e417078e36d49c7c6d00902399e2f56a5e97b0fc728ba195f883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>Adult</topic><topic>Aorta</topic><topic>Balloon treatment</topic><topic>Bayesian analysis</topic><topic>Coronary vessels</topic><topic>Edema</topic><topic>Embedding</topic><topic>Extracorporeal membrane oxygenation</topic><topic>Extracorporeal Membrane Oxygenation - methods</topic><topic>Health care facilities</topic><topic>Heart transplantation</topic><topic>Heart-Assist Devices</topic><topic>Humans</topic><topic>Intra-Aortic Balloon Pumping - methods</topic><topic>Knowledge management</topic><topic>Male</topic><topic>Mechanical unloading</topic><topic>Membranes</topic><topic>Mortality</topic><topic>Observational studies</topic><topic>Oxygenation</topic><topic>Patients</topic><topic>Pulmonary arteries</topic><topic>Quality of life</topic><topic>Randomization</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Registries</topic><topic>Shock, Cardiogenic - therapy</topic><topic>Survival</topic><topic>Survival analysis</topic><topic>Veins &amp; arteries</topic><topic>Ventricle</topic><topic>Ventricular assist devices</topic><topic>Weaning</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van Steenwijk, Myrthe P.J.</creatorcontrib><creatorcontrib>van Rosmalen, Joost</creatorcontrib><creatorcontrib>Elzo Kraemer, Carlos V.</creatorcontrib><creatorcontrib>Donker, Dirk W.</creatorcontrib><creatorcontrib>Hermens, Jeannine A.J.M.</creatorcontrib><creatorcontrib>Kraaijeveld, Adriaan O.</creatorcontrib><creatorcontrib>Maas, Jacinta J.</creatorcontrib><creatorcontrib>Akin, Sakir</creatorcontrib><creatorcontrib>Montenij, Leon J.</creatorcontrib><creatorcontrib>Vlaar, Alexander P.J.</creatorcontrib><creatorcontrib>van den Bergh, Walter M.</creatorcontrib><creatorcontrib>Oude Lansink-Hartgring, Annemieke</creatorcontrib><creatorcontrib>de Metz, Jesse</creatorcontrib><creatorcontrib>Voesten, Niek</creatorcontrib><creatorcontrib>Boersma, Eric</creatorcontrib><creatorcontrib>Scholten, Erik</creatorcontrib><creatorcontrib>Beishuizen, Albertus</creatorcontrib><creatorcontrib>Lexis, Chris P.H.</creatorcontrib><creatorcontrib>Peperstraete, Harlinde</creatorcontrib><creatorcontrib>Schiettekatte, Simon</creatorcontrib><creatorcontrib>Lorusso, Roberto</creatorcontrib><creatorcontrib>Gommers, Diederik A.M.P.J.</creatorcontrib><creatorcontrib>Tibboel, Dick</creatorcontrib><creatorcontrib>de Boer, Rudolf A.</creatorcontrib><creatorcontrib>Van Mieghem, Nicolas M.D.A.</creatorcontrib><creatorcontrib>Meuwese, Christiaan L.</creatorcontrib><creatorcontrib>REMAP ECMO LV unloading study group</creatorcontrib><creatorcontrib>REMAP ECMO LV unloading study group</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Physical Education Index</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The American heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van Steenwijk, Myrthe P.J.</au><au>van Rosmalen, Joost</au><au>Elzo Kraemer, Carlos V.</au><au>Donker, Dirk W.</au><au>Hermens, Jeannine A.J.M.</au><au>Kraaijeveld, Adriaan O.</au><au>Maas, Jacinta J.</au><au>Akin, Sakir</au><au>Montenij, Leon J.</au><au>Vlaar, Alexander P.J.</au><au>van den Bergh, Walter M.</au><au>Oude Lansink-Hartgring, Annemieke</au><au>de Metz, Jesse</au><au>Voesten, Niek</au><au>Boersma, Eric</au><au>Scholten, Erik</au><au>Beishuizen, Albertus</au><au>Lexis, Chris P.H.</au><au>Peperstraete, Harlinde</au><au>Schiettekatte, Simon</au><au>Lorusso, Roberto</au><au>Gommers, Diederik A.M.P.J.</au><au>Tibboel, Dick</au><au>de Boer, Rudolf A.</au><au>Van Mieghem, Nicolas M.D.A.</au><au>Meuwese, Christiaan L.</au><aucorp>REMAP ECMO LV unloading study group</aucorp><aucorp>REMAP ECMO LV unloading study group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A randomized embedded multifactorial adaptive platform for extra corporeal membrane oxygenation (REMAP ECMO) – design and rationale of the left ventricular unloading trial domain</atitle><jtitle>The American heart journal</jtitle><addtitle>Am Heart J</addtitle><date>2025-01</date><risdate>2025</risdate><volume>279</volume><spage>81</spage><epage>93</epage><pages>81-93</pages><issn>0002-8703</issn><issn>1097-6744</issn><eissn>1097-6744</eissn><abstract>The use of Extracorporeal Membrane Oxygenation (ECMO) remains associated with high rates of complications, weaning failure and mortality which can be partly explained by a knowledge gap on how to properly manage patients on ECMO support. To address relevant patient management issues, we designed a “Randomized Embedded Multifactorial Adaptive Platform (REMAP)” in the setting of ECMO (REMAP ECMO) and a first embedded randomized controlled trial (RCT) investigating the effects of routine early left ventricular (LV) unloading through intra-aortic balloon pumping (IABP). REMAP ECMO describes a registry-based platform allowing for the embedding of multiple response adaptive RCTs (trial domains) which can perpetually address the effect of relevant patient management issues on ECMO weaning success. A first trial domain studies the effects of LV unloading by means of an IABP as an adjunct to veno-arterial (V-A) ECMO versus V-A ECMO alone on ECMO weaning success at 30 days in adult cardiogenic shock patients admitted to the Intensive Care Unit (ICU). The primary outcome of this trial is “successful weaning from ECMO” being defined as a composite of survival without the need for mechanical circulatory support, heart transplantation, or left ventricular assist device (LVAD) at 30 days after initiation of ECMO. Secondary outcomes include the need for interventional escalation of LV unloading strategy, mechanistic endpoints, survival characteristics until 1 year after ECMO initiation, and quality of life. Trial data will be analysed using a Bayesian statistical framework. The adaptive design allows for a high degree of flexibility, such as response adaptive randomization and early stopping of the trial for efficacy or futility. The REMAP ECMO LV unloading study is approved by the Medical Ethical Committee of the Erasmus Medical Center and is publicly registered. This REMAP ECMO trial platform enables the efficient roll-out of multiple RCTs on relevant patient management issues. A first embedded trial domain will compare routine LV unloading by means of an IABP as an adjunct to V-A ECMO versus V-A ECMO alone. ClinicalTrials.gov, NCT05913622</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>39447716</pmid><doi>10.1016/j.ahj.2024.10.010</doi><tpages>13</tpages><orcidid>https://orcid.org/0009-0000-3880-2605</orcidid><orcidid>https://orcid.org/0000-0002-1901-1653</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0002-8703
ispartof The American heart journal, 2025-01, Vol.279, p.81-93
issn 0002-8703
1097-6744
1097-6744
language eng
recordid cdi_proquest_miscellaneous_3120594186
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Aorta
Balloon treatment
Bayesian analysis
Coronary vessels
Edema
Embedding
Extracorporeal membrane oxygenation
Extracorporeal Membrane Oxygenation - methods
Health care facilities
Heart transplantation
Heart-Assist Devices
Humans
Intra-Aortic Balloon Pumping - methods
Knowledge management
Male
Mechanical unloading
Membranes
Mortality
Observational studies
Oxygenation
Patients
Pulmonary arteries
Quality of life
Randomization
Randomized Controlled Trials as Topic
Registries
Shock, Cardiogenic - therapy
Survival
Survival analysis
Veins & arteries
Ventricle
Ventricular assist devices
Weaning
title A randomized embedded multifactorial adaptive platform for extra corporeal membrane oxygenation (REMAP ECMO) – design and rationale of the left ventricular unloading trial domain
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T23%3A54%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20randomized%20embedded%20multifactorial%20adaptive%20platform%20for%20extra%20corporeal%20membrane%20oxygenation%20(REMAP%20ECMO)%20%E2%80%93%20design%20and%20rationale%20of%20the%20left%20ventricular%20unloading%20trial%20domain&rft.jtitle=The%20American%20heart%20journal&rft.au=van%20Steenwijk,%20Myrthe%20P.J.&rft.aucorp=REMAP%20ECMO%20LV%20unloading%20study%20group&rft.date=2025-01&rft.volume=279&rft.spage=81&rft.epage=93&rft.pages=81-93&rft.issn=0002-8703&rft.eissn=1097-6744&rft_id=info:doi/10.1016/j.ahj.2024.10.010&rft_dat=%3Cproquest_cross%3E3134814054%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3134814054&rft_id=info:pmid/39447716&rft_els_id=S0002870324002722&rfr_iscdi=true